Kashiv BioSciences, LLC

Quick facts

Marketed products

• RELEUKO · Other
• FYLNETRA · Other
  Pegfilgrastim binds to specific cell surface receptors on hematopoietic cells, stimulating their proliferation, differentiation, and functional activation.

Phase 3 pipeline

• Xolair Prefilled Syringe · Immunology / Allergy
  Xolair (omalizumab) is a monoclonal antibody that binds to circulating immunoglobulin E (IgE) and prevents its interaction with high-affinity IgE receptors on mast cells and basophils, thereby reducing allergic cascade activation.

Phase 1 pipeline

• Fylntera · Other
• KSHN001034

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kashiv BioSciences, LLC portfolio CI brief
• Kashiv BioSciences, LLC pipeline updates RSS